• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性亨廷顿病的临床和遗传特征。

Clinical and genetic characteristics of late-onset Huntington's disease.

机构信息

Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.

Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Parkinsonism Relat Disord. 2019 Apr;61:101-105. doi: 10.1016/j.parkreldis.2018.11.009. Epub 2018 Nov 29.

DOI:10.1016/j.parkreldis.2018.11.009
PMID:30528461
Abstract

BACKGROUND

The frequency of late-onset Huntington's disease (>59 years) is assumed to be low and the clinical course milder. However, previous literature on late-onset disease is scarce and inconclusive.

OBJECTIVE

Our aim is to study clinical characteristics of late-onset compared to common-onset HD patients in a large cohort of HD patients from the Registry database.

METHODS

Participants with late- and common-onset (30-50 years)were compared for first clinical symptoms, disease progression, CAG repeat size and family history. Participants with a missing CAG repeat size, a repeat size of ≤35 or a UHDRS motor score of ≤5 were excluded.

RESULTS

Of 6007 eligible participants, 687 had late-onset (11.4%) and 3216 (53.5%) common-onset HD. Late-onset (n = 577) had significantly more gait and balance problems as first symptom compared to common-onset (n = 2408) (P < .001). Overall motor and cognitive performance (P < .001) were worse, however only disease motor progression was slower (coefficient, -0.58; SE 0.16; P < .001) compared to the common-onset group. Repeat size was significantly lower in the late-onset (n = 40.8; SD 1.6) compared to common-onset (n = 44.4; SD 2.8) (P < .001). Fewer late-onset patients (n = 451) had a positive family history compared to common-onset (n = 2940) (P < .001).

CONCLUSIONS

Late-onset patients present more frequently with gait and balance problems as first symptom, and disease progression is not milder compared to common-onset HD patients apart from motor progression. The family history is likely to be negative, which might make diagnosing HD more difficult in this population. However, the balance and gait problems might be helpful in diagnosing HD in elderly patients.

摘要

背景

晚发性亨廷顿病(>59 岁)的频率较低,且临床病程较轻。然而,关于晚发性疾病的既往文献很少且尚无定论。

目的

我们旨在通过对亨廷顿病登记数据库中的大型患者队列进行研究,比较晚发性和常见发病的亨廷顿病患者的临床特征。

方法

比较了晚发性和常见发病(30-50 岁)患者的首发临床症状、疾病进展、CAG 重复大小和家族史。排除 CAG 重复大小缺失、重复大小≤35 或 UHDRS 运动评分≤5 的患者。

结果

在 6007 名合格的参与者中,有 687 名患有晚发性(11.4%)和 3216 名(53.5%)常见发病的亨廷顿病。与常见发病(n=2408)相比,晚发性(n=577)患者首发症状更常见为步态和平衡问题(P<0.001)。整体运动和认知表现(P<0.001)更差,但与常见发病组相比,疾病运动进展更慢(系数,-0.58;SE 0.16;P<0.001)。晚发性(n=40.8;SD 1.6)患者的重复大小明显低于常见发病(n=44.4;SD 2.8)(P<0.001)。与常见发病(n=2940)相比,晚发性(n=451)患者的阳性家族史较少(P<0.001)。

结论

与常见发病的亨廷顿病患者相比,晚发性患者首发症状更常为步态和平衡问题,且疾病进展并不比常见发病患者更轻,除运动进展外。该人群的家族史可能为阴性,这可能使诊断 HD 更加困难。然而,平衡和步态问题可能有助于在老年患者中诊断 HD。

相似文献

1
Clinical and genetic characteristics of late-onset Huntington's disease.迟发性亨廷顿病的临床和遗传特征。
Parkinsonism Relat Disord. 2019 Apr;61:101-105. doi: 10.1016/j.parkreldis.2018.11.009. Epub 2018 Nov 29.
2
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.青少年亨廷顿病的生物学和临床表现:回顾性分析。
Lancet Neurol. 2018 Nov;17(11):986-993. doi: 10.1016/S1474-4422(18)30294-1. Epub 2018 Sep 19.
3
Clinical characterization of dystonia in adult patients with Huntington's disease.亨廷顿病成年患者的肌张力障碍临床特征。
Eur J Neurol. 2017 Sep;24(9):1140-1147. doi: 10.1111/ene.13349. Epub 2017 Jun 29.
4
The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.成年亨廷顿病患者中晚发型与早发型的临床特征和进展。
J Huntingtons Dis. 2020;9(3):275-282. doi: 10.3233/JHD-200404.
5
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.大型欧洲队列中晚发性亨廷顿病的临床和遗传特征。
Eur J Neurol. 2022 Jul;29(7):1940-1951. doi: 10.1111/ene.15340. Epub 2022 Apr 17.
6
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.鉴定与亨廷顿病进展相关的遗传变异:全基因组关联研究。
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
7
A clinical study of patients with genetically confirmed Huntington's disease from India.一项针对来自印度、基因检测确诊为亨廷顿舞蹈症患者的临床研究。
J Neurol Sci. 2001 Sep 15;190(1-2):73-8. doi: 10.1016/s0022-510x(01)00593-7.
8
Identification of extreme motor phenotypes in Huntington's disease.亨廷顿舞蹈病极端运动表型的鉴定。
Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):283-294. doi: 10.1002/ajmg.b.32514. Epub 2016 Nov 21.
9
The Impact of Family History on the Clinical Features of Huntington's Disease.家族史对亨廷顿舞蹈病临床特征的影响
J Huntingtons Dis. 2017;6(4):327-335. doi: 10.3233/JHD-170256.
10
Adult-onset Huntington's disease that presented without chorea.无舞蹈症表现的成年起病型亨廷顿病
Intern Med. 2013;52(18):2121-2. doi: 10.2169/internalmedicine.52.0433.

引用本文的文献

1
Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington's Disease.亨廷顿舞蹈病R6/2小鼠模型中补充丙酸盐后的抗炎作用研究
Int J Mol Sci. 2025 Apr 2;26(7):3318. doi: 10.3390/ijms26073318.
2
A Practical Guide for Diagnostic Investigations and Special Considerations in Patients With Huntington's Disease in Korea.韩国亨廷顿舞蹈症患者诊断检查及特殊注意事项实用指南。
J Mov Disord. 2025 Jan;18(1):17-30. doi: 10.14802/jmd.24232. Epub 2024 Dec 26.
3
A Case of Late-Onset De Novo Huntington's Disease Diagnosed via F-FDG PET.
一例通过F-FDG PET诊断的迟发性新发亨廷顿舞蹈病病例
Dement Neurocogn Disord. 2024 Oct;23(4):245-247. doi: 10.12779/dnd.2024.23.4.245. Epub 2024 Oct 14.
4
Clinical and Genetic Characteristics Associated With Survival Outcome in Late-Onset Huntington's Disease in South Korea.韩国晚发性亨廷顿舞蹈病生存结局相关的临床与遗传学特征
J Clin Neurol. 2024 Jul;20(4):394-401. doi: 10.3988/jcn.2023.0329. Epub 2024 Apr 2.
5
Physiological and pathological consequences of exosomes at the blood-brain-barrier interface.血脑屏障界面外泌体的生理和病理后果。
Cell Commun Signal. 2023 May 19;21(1):118. doi: 10.1186/s12964-023-01142-z.
6
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.大型欧洲队列中晚发性亨廷顿病的临床和遗传特征。
Eur J Neurol. 2022 Jul;29(7):1940-1951. doi: 10.1111/ene.15340. Epub 2022 Apr 17.
7
The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease.微小 RNA 在亨廷顿病发病机制和治疗中的调控作用。
J Biomed Sci. 2021 Aug 19;28(1):59. doi: 10.1186/s12929-021-00755-1.
8
An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography.急诊科的一种罕见步态障碍:实质经颅多普勒超声定量评估的作用
Quant Imaging Med Surg. 2021 May;11(5):2195-2200. doi: 10.21037/qims-20-982.
9
The future of genomics in Ireland - focus on genomics for health.爱尔兰基因组学的未来——聚焦于健康领域的基因组学。
HRB Open Res. 2020 Dec 4;3:89. doi: 10.12688/hrbopenres.13187.1. eCollection 2020.
10
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.亨廷顿舞蹈症患者精神、认知及运动异常的发生时间与影响
Neurology. 2021 May 11;96(19):e2395-e2406. doi: 10.1212/WNL.0000000000011893. Epub 2021 Mar 25.